PolyPeptide Group AG

PolyPeptide Group AG

43.80
EUR
+0.20
(+0.46%)
1.67BMarket Cap
Mar 09Next Earn

Total Valuation

EUR

As of June 30, 2026, PolyPeptide Group AG carries a market capitalization of 1.67B, placing it among publicly traded companies globally. Its enterprise value stands at 1.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.67B
Enterprise Value1.75B

Important Dates

PolyPeptide Group AG's next confirmed earnings release is scheduled for March 9, 2027.

Earnings Date3/9/2027

Share Statistics

As of June 30, 2026, PolyPeptide Group AG has 33.02M shares outstanding.

Shares Outstanding33.02M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio4.75
P/TBV Ratio4.84

Financial Position

As of June 30, 2026, PolyPeptide Group AG maintains a current ratio of 1.64, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

Current Ratio1.64
Quick Ratio0.28
Debt / Equity39.60

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count1,469.00

Stock Price Statistics

EUR

As of the close on November 17, 2026, PolyPeptide Group AG's stock has gained approximately 72.44% over the past 52 weeks. The 50-day moving average sits at 46.35, while the 200-day moving average is 41.45.

52-Week Price Change72.44%
50-Day Moving Average46.35
200-Day Moving Average41.45

Balance Sheet

EUR

As of June 30, 2026, PolyPeptide Group AG holds 59.03M in cash and equivalents against 139.08M in total debt, resulting in a net debt position of 60.51M. Total book value stands at 351.21M, with working capital of 136.25M providing operational flexibility.

Cash & Cash Equivalents59.03M
Total Debt139.08M
Net Debt60.51M
Equity (Book Value)351.21M
Book Value Per Share10.64
Working Capital136.25M